Cargando…
A biodegradable rectal balloon implant to protect the rectum during prostate cancer radiotherapy for a patient with active Crohn’s disease
BACKGROUND: Radiotherapy in patients with active inflammatory bowel disease (IBD) is usually considered an absolute exclusion criterion for prostate cancer radiotherapy treatment. There are no reports available on the use of a biodegradable rectal balloon implantation (RBI) in patients with active I...
Autores principales: | Vanneste, Ben G.L., Van Limbergen, Evert J., van de Beek, Kees, van Lin, Emile, Lutgens, Ludy, Lambin, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033750/ https://www.ncbi.nlm.nih.gov/pubmed/32095571 http://dx.doi.org/10.1016/j.tipsro.2018.01.004 |
Ejemplares similares
-
Implantation of a biodegradable rectum balloon implant: Tips, Tricks and Pitfalls
por: Vanneste, Ben G. L., et al.
Publicado: (2017) -
Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?
por: Vanneste, Ben G.L., et al.
Publicado: (2021) -
Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model
por: Vanneste, Ben G.L., et al.
Publicado: (2022) -
Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity
por: Opbroek, Thirza, et al.
Publicado: (2023) -
Dynamics of rectal balloon implant shrinkage in prostate VMAT: Influence on anorectal dose and late rectal complication risk
por: Vanneste, Ben G. L., et al.
Publicado: (2017)